The primary benefits of liraglutide include: Clinically meaningful weight loss (6 to 8% average, up to 10%+ in early responders) Improved glycemic control and HbA1c reduction in type 2 diabetes Demonstrated cardiovascular risk reduction (13% reduction in MACE in the LEADER trial) Reduced progression from prediabetes to type 2 diabetes Approved for adolescents aged 12+ (obesity) and children aged 10+ (diabetes) The longest safety track record of any GLP-1 receptor agonist How It Works GLP-1 Receptor Activation Liraglutide functions as a potent agonist at GLP-1 receptors distributed throughout the pancreas, brain, heart, and gastrointestinal tract
If NA-931 succeeds, it will validate the concept of unimolecular polypharmacy one molecule hitting multiple targets
Berberine's glucose and lipid effects appear at 900 to 1,500 mg daily in divided doses, a range replicated across multiple meta-analyses (Liang et al., 2019, 28 trials, 2,313 patients)
What semaglutide reveals about weight problems To understand how semaglutide causes some people to eat less, its helpful to understand what hormones do
